Current treatment status-Did not start treatment yet - Page 6 of 37 Posts on Medivizor
Navigation Menu

Current treatment status-Did not start treatment yet Posts on Medivizor

Searching for children with advanced Hodgkin lymphoma to test a new chemoimmunotherapy combination regimen

Posted by on May 24, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study is evaluating the effectiveness of brentuximab vedotin (Adcetris) plus chemotherapy for children with advanced Hodgkin lymphoma (HL). The main outcome to be measured will be the number of patients who respond to treatment. The details Brentuximab vedotin is being tested to treat children who have advanced HL. Brentuximab...

Read More

Further surgery or non-surgical options for patients with remaining breast cancer after surgery

Further surgery or non-surgical options for patients with remaining breast cancer after surgery

Posted by on May 19, 2019 in Breast cancer | 0 comments

In a nutshell This study evaluated whether treating breast cancer that has not been completely removed with more surgery was more effective than non-surgical options such as chemotherapy. This study found that there was no difference in outcomes between treating with further surgery versus treating with a non-surgical option. Some...

Read More

Searching for patients with early-stage HER2+ breast cancer to trial a new treatment regime

Posted by on Apr 24, 2019 in Breast cancer | 0 comments

In a nutshell This study will examine how safe and effective the medication atezolizumab (Tecentriq) is in combination with other anti-cancer medicines for treating early stage HER2+ breast cancer. The main outcome that will be measured is how many patients completely respond to treatment, with no trace of the cancer remaining. The details...

Read More

Searching for patients with HIV-positive lymphoma to test EPOCH-R chemotherapy

Posted by on Apr 22, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study is evaluating the effectiveness of EPOCH-R chemotherapy for patients with non-Hodgkin's lymphoma (NHL) who are HIV-positive. The main outcome to be measured will be survival without cancer growing or spreading. This study is recruiting in Bethesda, Maryland, United States. The details Patients with NHL who are...

Read More

Evaluating PCR therapy for previously untreated indolent non-Hodgkin’s lymphoma

Evaluating PCR therapy for previously untreated indolent non-Hodgkin’s lymphoma

Posted by on Mar 31, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the long-term effectiveness and safety of a new chemotherapy regimen in patients with previously untreated indolent (painless) non-Hodgkin’s lymphoma (NHL). This study concluded that this regimen is effective and well-tolerated for these patients. Some background There are three common types of painless NHL....

Read More

Searching for patients to try a new combination of treatments for Hodgkin lymphoma.

Posted by on Mar 26, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This trial is investigating the effects of AVD [doxorubicin (Adriamycin), vinblastine (Velban), and dacarbazine (DTIC)] with brentuximab vedotin (Adcetris) induction chemotherapy, plus nivolumab (Opdivo) for Hodgkin lymphoma (HL). The main outcome to be measured is survival without cancer worsening 3 years after treatment. The details...

Read More

Comparing urinary function after robotic surgery or radical perineal surgery for early stage prostate cancer

Comparing urinary function after robotic surgery or radical perineal surgery for early stage prostate cancer

Posted by on Mar 5, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate two less invasive surgeries in the treatment of localized prostate cancer (PCa). This study found that there was no difference in urinary symptoms 12 months after the two methods.  Some background Prostate surgery is a treatment option for prostate cancer (PCa). This surgery can be carried out by classic...

Read More

Predicting treatment success in early RA: can biomarkers predict methotrexate response?

Predicting treatment success in early RA: can biomarkers predict methotrexate response?

Posted by on Feb 26, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if biomarkers (BMs) can predict the response to methotrexate (MTX) in early rheumatoid arthritis (RA). They found that the level of BMs at baseline could predict the success of MTX treatment. Some background Rheumatoid arthritis (RA) is a condition caused by inflammation. This leads to painful swelling...

Read More

Evaluating A+AVD for patients with newly diagnosed advanced Hodgkin lymphoma

Evaluating A+AVD for patients with newly diagnosed advanced Hodgkin lymphoma

Posted by on Feb 17, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of brentuximab vedotin (Adcetris) plus chemotherapy for patients with advanced (stage 3 – 4) Hodgkin’s lymphoma (HL). This study concluded that this treatment is effective for these patients. Some background The most commonly used frontline chemotherapy regimen for advanced HL...

Read More

Looking for men with newly diagnosed prostate cancer to test an immune based therapy, Sipuleucel-T

Looking for men with newly diagnosed prostate cancer to test an immune based therapy, Sipuleucel-T

Posted by on Feb 9, 2019 in Prostate cancer | 0 comments

In a nutshell This study evaluates the effectiveness of an immunotherapy in the treatment of newly diagnosed prostate cancer. The main outcome to be measured in this trial is the number of patients whose cancer does not progress within 3 years after immunotherapy injection. This trial is taking place in many sites across the USA.  The details...

Read More